Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

NCT06544798 is registered in ClinicalTrials.gov with MeiraGTx, LLC as lead sponsor.

NCT NCT06544798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06544798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Lead sponsor
MeiraGTx, LLC
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
August 2, 2024
Completion date
February 29, 2032
Enrollment
276 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

grade 2 and 3 late xerostomia caused by radiotherapy for cancers of the upper aerodigestive tract, excluding the parotid glands